Early-stage melanoma and hematopoietic stem cell transplantation outcomes
structure encroaching at least 0.5 mm into the arterial lumen or having a thickness greater than 50% of the surrounding intima-media thickness. Table I exhibits the anthropometric, clinical, and biochemical data of participants.
To our best knowledge, this is the first study to evaluate the presence of femoral atherosclerotic plaques as a screening test for atherosclerosis in patients with psoriasis. The prevalence of femoral plaques but not carotid plaques was significantly higher in the patients with psoriasis than in age-, sex-, and body mass indexematched controls (P \ .006), whereas the prevalence of femoral plaques among the patients was 2-fold higher than that of carotid plaques (P \ .008) (Fig 1) . According to the present findings, ultrasound study of femoral arteries is more useful than the study of carotid arteries to identify atherosclerosis in patients with psoriasis. We searched Duke University Medical Center's historical database of 4528 adult HSCT patients from 1996 to 2017 for patients who had a melanoma before receiving their transplant. One patient whose indication for HSCT was metastatic melanoma was excluded from this study. We included 23 patients (0.5%) with a total of 27 pre-HSCT melanomas (Table I) . A total of 7 patients (30%) underwent allogeneic HSCT, whereas the rest received an autologous transplant. A total of 13 patients (56.5%) were exposed to ionizing radiation (Table II) .
Only 1 patient (4.3%) developed a new melanoma (in situ) 3.1 years after allogeneic HSCT and 32.0 years after the initial melanoma. This patient did not have graft-versus-host disease (GVHD), had only 1 primary melanoma before HSCT, received a nonablative preparative regimen, and was successfully treated with local excision.
There were no recurrences of melanoma. At the median follow-up time of 2.0 years (range 0.02-13.1 years) after HSCT, 5 patients (26.1%) had died (none owing to melanoma). GVHD occurred following HSCT in 42.9% of patients who underwent allogeneic HSCT. This rate was not significantly different from the rate of 32.0% among the patients who underwent allogeneic HSCT without a history of melanoma (P ¼ .69 with use of a chi-square test).
Our cohort had a wide range of follow-up times from their most recent pretransplant melanoma to their last post-HSCT visit (median, 11.4 years; range, 2.1-42.1 years). Other authors have estimated the risk of a second melanoma at 10 years to be 5% to 12%, 1, 2 but this rate was increased in those who had risk factors such as a family history of melanoma (14%), a thin primary melanoma, and a history of other cancers. In all, 25% of our cohort had more than 1 pre-HSCT melanoma. The 10-year risk of development of a third melanoma in patients with 2 previous melanomas has been estimated at 27.7%. 2 Other studies, as well as our unpublished data, have suggested that GVHD increases the risk for secondary cutaneous malignancies, likely as a result of increased immunosuppression. There was, however, no significant difference in the GVHD rate between our cohort and the rest of our allogeneic HSCT population. Finally, roughly 75% of the cohort was still alive at the 2.0-year follow-up, which was similar to the previously reported 1-(;80%) and 3-year (;60%) survival rates following HSCT. 3 Although limited by its small size, short median duration of post-HSCT follow-up, and single-center and retrospective nature, our study is notable in that both patients who had received allogeneic transplants and patients who had received autologous transplants had low rates of a second primary or recurrent melanoma despite having significant risk factors. 4, 5 Trends in the dermatology residency match from 2007 to 2018: Implications for the dermatology workforce
To the Editor: Dermatology services remain undersupplied in the United States, stemming from both the limited number and geographic distribution of dermatologists. 1, 2 As an important determinant of workforce growth, the quantity of dermatology residency positions may be a constraining factor.
To identify match trends, we analyzed National Resident Matching Program (NRMP) Main Residency Match data from 2007 to 2018 and all Charting Outcomes reports (available only for 2007, 2009, 2011, 2014, and 2016) . For each year, we collected data on applicants, positions, and educational characteristics of matched US allopathic seniors in dermatology and in all specialties. Applicants were considered dermatology applicants if dermatology was the first or only specialty ranked. All statistical analyses were conducted by using Microsoft Excel (Microsoft Corp, Redmond, WA). The University of Pennsylvania Institutional Review Board exempted this study from review.
Between 2007 and 2018, increases in total applicants and US allopathic senior applicants for all categorical and preliminary specialties (32.8% and 23.8%, respectively) exceeded those for dermatology (12.4% and 10.8%, respectively) ( Table I ). The numbers of total applicants per position and US allopathic senior applicants per position remained relatively constant for all categorical and preliminary specialties but declined from 2007 to 2012 before stabilizing for dermatology. Similarly, US allopathic senior match rates for dermatology increased from 61.7% in 2007 to 82.7% in 2012 before plateauing. The fill rates for dermatology ranged from 97.0% to 100.0%.
Among matched US allopathic seniors, the mean number of abstracts, presentations, and publications more than doubled for all specialties (increasing from 2.2 to 4.7) and for dermatology (increasing from 5.7 to 11.7) (Table II) . Within dermatology, PhD degrees became slightly less common (decreasing from 11.6% to 8.0%), whereas other graduate degrees became more common (increasing from 6.8% to 12.8%).
Our findings indicate that the proportion of US seniors failing to match in dermatology remains substantial, despite earlier improvement in match rates and the number of applicants per NRMP-filled position. In addition, growth in the quantity of presented and published works among matched dermatology applicants has outpaced that among all matched applicants.
The fact that there are more publications among matched dermatology applicants suggests increased interest in research and pressure to publish. 3, 4 Still, whether higher scholarly activity in applications reflects any higher likelihood to pursue an academic career is unclear. 5 The increasing prevalence of non-PhD graduate degrees may reflect either greater enrollment in combined degree programs such as an MD/MPH or MD/MBA program, or advanced training before medical school.
Our study is limited by exclusion of positions filled outside the NRMP. The likely primary driver of the improved match rate from 2007 to 2012 was slower than overall growth in the number of dermatology applicants. Along with fill rates near
